Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Total article views   HTML views PDF downloads Totals
7,048 Dovepress* 6,944+ 1,425 8,369
PubMed Central* 104 50 154
Totals 7,048 1,475 8,523
*Since 19 April 2017

View citations on PubMed Central and Google Scholar